Resources for Health Care Professionals



To support the health care professionals who are so integral to Genzyme's mission, we've compiled a summary of key pages of interest from throughout Genzyme.com, plus some of our other most relevant resources.
Contact Genzyme

Side by side with Genzyme's commitment to patients is our commitment to the health care professionals who treat and care for them. Please reach out to us if you have any questions or concerns.

Ask Medical Questions

Genzyme Medical Information is staffed with experts in our products and the diseases they treat, who are available to answer your questions. In the U.S., you can call 800-745-4447 (toll-free) or 617-768-9000, and choose option #2, Monday through Friday between 8 a.m. and 6 p.m. (EST).

If you are outside the U.S. you can use your online form to send a message to Medical Information's regional contacts:

Report Side Effects

If you have a patient taking a Genzyme product who is experiencing side effects, please report this information to us by contacting Genzyme Medical Information - see above for phone numbers for the U.S. and links to our online form for other regions.

In the U.S., you are encouraged to report negative side effects of prescription drugs to the FDA via its MedWatch program:

 Find out more about reporting side effects to Genzyme

Working Together

Genzyme collaborates with and supports health care professionals in many ways, from co-sponsoring clinical trials to providing research and education grants.

Clinical Trials

Grants from Genzyme

  • Get information on our investigator-sponsored studies program
  • Apply online for Genzyme's other research and education grants

Committed to Transparency

At Genzyme we are focused on making a difference in patients’ lives. To make tomorrow’s therapeutic solutions real, we seek to innovate with other individuals and organizations, who like us, aim to improve patient health. We work with physicians and teaching hospitals as well as patient associations and others involved in healthcare. We are fully committed to transparency; it is important to us to foster an understanding of these interactions and to prevent any real or perceived conflict of interest. As part of the federal Open Payments (Physician Payments Sunshine Act), overseen by the Centers for Medicare and Medicaid Services (CMS) any payment or transfer of value we make to a physician or teaching hospital is subject to collection and potential public reporting. These payments are separate and in addition to existing state transparency reporting requirements. We continue to be dedicated to complying with state and federal laws and regulations today and in the future.

Genzyme is a Sanofi company. See Sanofi's full Transparency statement

Resources for Your Patients

Genzyme is an industry leader in providing support services and programs to help facilitate patient access to treatment, including help with understanding insurance plans, finding alternative forms of funding, and opportunities to obtain free or subsidized treatment.

Find out more about Genzyme's patient support services

You may also want to direct your patients to Genzyme.com to explore our educational information and resources.

Disease Registries

Genzyme has established registries - large, often multinational databases to which physicians contribute clinical data on patients - for several lysosomal storage disorders (LSDs), to help pool knowledge and improve understanding of these rare diseases. Get more information and enroll patients online at the registries' websites:

About Our Products

Genzyme's specialized product portfolio helps address serious medical needs, including rare genetic diseases, through innovative therapies. To see our current product list and get quick access to Prescribing Information for each product, visit the product information page.

For our treatments approved in the U.S., the individual product websites are the best source for detailed information about the product, supporting services, and more.

Genzyme U.S. Product Websites

Products
Aldurazyme® (laronidase)

U.S. Prescribing Information, including boxed WARNING (PDF)

AUBAGIO® (teriflunomide) tablets

U.S. Prescribing Information, including boxed WARNING (PDF)
U.S. Medication Guide (PDF)

AUBAGIO® (teriflunomide) tablets

U.S. Prescribing Information, including boxed WARNING (PDF)
U.S. Medication Guide (PDF)

Cerdelga® (eliglustat) capsules

U.S. Prescribing Information (PDF)

Cerezyme® (imiglucerase for injection)

U.S. Prescribing Information (PDF)

Fabrazyme® (agalsidase beta)

U.S. Prescribing Information (PDF)

LEMTRADA® (alemtuzumab)

U.S. Prescribing Information, including boxed WARNING (PDF)
U.S. Medication Guide (PDF)

Lumizyme® (alglucosidase alfa)

U.S. Prescribing Information, including boxed WARNING (PDF)

Thyrogen® (thyrotropin alfa for injection)

U.S. Prescribing Information (PDF)

Last Updated: 7/28/2016
GZUS.GZ.16.02.0563a
Contact Us
Genzyme Corporation

500 Kendall Street
Cambridge, MA 02142
USA
T: 617-252-7500
F: 617-252-7600

Send Email
infoBox